Literature DB >> 34389164

Minimally invasive Ivor Lewis esophagectomy: Robot-assisted versus laparoscopic-thoracoscopic technique. Systematic review and meta-analysis.

Cristian A Angeramo1, Camila Bras Harriott1, María A Casas1, Francisco Schlottmann2.   

Abstract

BACKGROUND: Evidence comparing conventional minimally invasive esophagectomy (CMIE) via laparoscopy and thoracoscopy with robot-assisted minimally invasive esophagectomy (RAMIE) is scarce. The aim of this meta-analysis was to compare surgical outcomes after CMIE and RAMIE with an intrathoracic anastomosis.
METHODS: A systematic literature search was performed to identify original articles analyzing outcomes after CMIE and RAMIE. Main surgical outcomes included operative time, intraoperative blood loss, anastomotic leak rates, pneumonia, overall morbidity, length of stay (LOS), and 30-day mortality. Oncologic outcomes included lymph node yield and R0 resections rates. A meta-analysis of proportions and linear regression models were used to assess the effect of each procedure on the different outcomes.
RESULTS: A total of 6,249 patients were included for analysis; 5,275 (84%) underwent CMIE and 974 (16%) RAMIE. Robotic esophagectomy had longer operative time and less intraoperative blood loss. Anastomotic leakage rates were similar with both approaches. Patients undergoing RAMIE had significantly lower rates of postoperative pneumonia (OR 0.46, 95% CI 0.35-0.61, P < .0001) and overall morbidity (OR 0.67, 95% CI 0.58-0.79, P < .0001). Median LOS was similar in both procedures (RAMIE: 12.1 versus CMIE: 11.9 days, P = .64). Similar mortality rates were found after RAMIE and CMIE (OR 0.69, 95% CI 0.34-1.38, P = .29). Lymph node yield was similar in both procedures, but RAMIE was associated with higher rates of R0 resection (OR 2.84, 95% CI 1.53-5.26, P < .001).
CONCLUSION: Patients undergoing robotic esophagectomy have less intraoperative blood loss, lower rates of postoperative pneumonia, reduced overall morbidity, and higher rates of R0 resections, as compared with those undergoing a laparoscopic-thoracoscopic esophageal resection.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34389164     DOI: 10.1016/j.surg.2021.07.013

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

Review 1.  Today's Mistakes and Tomorrow's Wisdom in the Surgical Treatment of Barrett's Adenocarcinoma.

Authors:  Giovanni Maria Garbarino; Mark Ivo van Berge Henegouwen; Suzanne Sarah Gisbertz; Wietse Jelle Eshuis
Journal:  Visc Med       Date:  2022-05-24

Review 2.  The Implementation of Minimally Invasive Surgery in the Treatment of Esophageal Cancer: A Step Toward Better Outcomes?

Authors:  Tania Triantafyllou; Pieter van der Sluis; Richard Skipworth; Bas P L Wijnhoven
Journal:  Oncol Ther       Date:  2022-08-10

3.  Propensity-Matched Analysis of the Short-Term Outcome of Robot-Assisted Minimally Invasive Esophagectomy Versus Conventional Thoracoscopic Esophagectomy in Thoracic Esophageal Cancer.

Authors:  Takeo Fujita; Kazuma Sato; Asako Ozaki; Tomohiro Akutsu; Hisashi Fujiwara; Takashi Kojima; Hiroyuki Daiko
Journal:  World J Surg       Date:  2022-04-30       Impact factor: 3.282

Review 4.  Outcomes of Minimally Invasive and Robot-Assisted Esophagectomy for Esophageal Cancer.

Authors:  Kian C Banks; Diana S Hsu; Jeffrey B Velotta
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

Review 5.  Intraoperative fluorescence imaging in esophagectomy and its application to the robotic platform: a narrative review.

Authors:  Marianna V Papageorge; Uma M Sachdeva; Lana Y Schumacher
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

Review 6.  Features and applications of energy devices for prone robot-assisted minimally invasive esophagectomy: a narrative review.

Authors:  Noriyuki Hirahara; Takeshi Matsubara; Hikota Hayashi; Yoshitsugu Tajima
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.